Results 11 to 20 of about 150,265 (357)
Serum hepatitis B surface antigen (HBsAg) kinetics in hepatitis B e antigen (HBeAg)-negative chronic hepatitis B [PDF]
Hepatology International, 2012 Abstract Background We investigated the differences in HBsAg kinetics at different levels of viremia in hepatitis B e antigen (HBeAg)-negative chronic hepatitis B (CHB). Methods We compared HBsAg levels among HBeAg-negative CHB patients with persistently undetectable HBV ...
Seto, Wai-Kay +7 more
openaire +4 more sources
Immunomodulatory effect of hepatitis B virus (HBV) antigens and MRSA antigens on immune response
Medical Journal of BabylonBackground: Methicillin-resistant Staphylococcus aureus is one of the most common human invaders and causes different types of illness worldwide.
Entidhar A. Hadi +2 more
doaj +2 more sources
Long-term HBsAg clearance, relapse, and safety following tenofovir or entecavir discontinuation in non-cirrhotic, HBeAg-negative chronic hepatitis [PDF]
Scientific ReportsStopping nucleos(t)ide analogues (NAs) can foster hepatitis B surface antigen (HBsAg) clearance, yet comparative data for tenofovir disoproxil fumarate (TDF) and entecavir (ETV) are scarce.
Onuma Sattayalertyanyong +5 more
doaj +2 more sources
Correlation between serum quantitative HBsAg and HBV DNA levels in chronic hepatitis B patients [PDF]
Vojnosanitetski Pregled, 2023 Background/Aim. Quantitative hepatitis B virus (HBV) surface antigen (qHBsAg) has become increasingly wide-spread in the last few years in both diagnostic and therapeutic protocols for HBV infection.
Pete Maria +5 more
doaj +1 more source
Prevalence of hepatitis B in dental patients
Journal of Indian Academy of Oral Medicine and Radiology, 2023 Background: Hepatitis B virus (HBV) infection is one of the leading causes of death worldwide. The most important marker for HBV infection is HBsAg. In case of diagnosis of infectious disease, discordant results may have serious consequences among the ...
Ashmita Kaur R. Chawla +2 more
doaj +1 more source
Nuclear Expression of Hepatitis B Virus X Protein Is Associated with Recurrence of Early-Stage Hepatocellular Carcinomas: Role of Viral Protein in Tumor Recurrence [PDF]
Journal of Pathology and Translational Medicine, 2016 Background: Hepatitis B virus (HBV) plays well-known roles in tumorigenesis of hepatocellular carcinoma (HCC) in infected patients. However, HBV-associated protein status in tumor tissues and the relevance to tumor behavior has not been reported.
Jing Jin +6 more
doaj +1 more source
Hepatitis B e antigen-negative chronic hepatitis B [PDF]
Hepatology, 2001 Summary HBeAg-negative CHB has now a worldwide distribution, developing in the course of HBeAg-positive chronic HBV infection during or after the phase of HBeAg loss and its seroconversion to anti-HBe. It is caused by replicating noncytopathic HBV mutants either unable to produce HBeAg (precore mutants) or with down-regulated transcription of the ...
Hadziyannis, SJ, Vassilopoulos, D
openaire +3 more sources
Iranian Journal of Microbiology, 2023 Background and Objectives: Hepatitis B is a common chronic viral infection in humans. Universal use of hepatitis B vaccine is crucial for controlling the infection, but the duration of vaccine-induced immunity remains uncertain.
Majid Najafi-Asl +3 more
doaj +1 more source
Biomedical Journal, 2022 Background: To evaluate the protective efficacy of a hepatitis B (HB) vaccination program in Taiwan among high-risk children. Methods: Children born to HBeAg-positive mothers from 2001 to 2010 were invited back.
Chen-Hsuan Wu +3 more
doaj +1 more source
Haseki Tıp Bülteni, 2021 Aim:The presence of hepatitis B core antibody (HBcAb) is an indication of exposure to hepatitis B virus infection. We aimed to investigate the rates of positive HBcAb and its’ association with demographical and laboratory parameters among patients ...
Ilter Bozaci, Selma Tosun
doaj +1 more source